-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, G6hFuGgTZ2yKVl9nEeGysWu+WET+ZzT+NZjhE6Y6LkCj1wcxWFQzgpmBKNvls1NF gCgeii+orDmFovPLjDRFCA== 0001181431-04-017729.txt : 20040326 0001181431-04-017729.hdr.sgml : 20040326 20040326184920 ACCESSION NUMBER: 0001181431-04-017729 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040227 FILED AS OF DATE: 20040326 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PATOU GARY CENTRAL INDEX KEY: 0001283535 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-10824 FILM NUMBER: 04694318 BUSINESS ADDRESS: STREET 1: 100 BEAVER ST CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 6508371850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENOME THERAPEUTICS CORP CENTRAL INDEX KEY: 0000356830 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 042297484 STATE OF INCORPORATION: MA FISCAL YEAR END: 0831 BUSINESS ADDRESS: STREET 1: 1OO BEAVER ST CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7813982300 MAIL ADDRESS: STREET 1: 100 BEAVER STREET CITY: WALTHAM STATE: MA ZIP: 02453 FORMER COMPANY: FORMER CONFORMED NAME: COLLABORATIVE RESEARCH INC DATE OF NAME CHANGE: 19920703 3 1 rrd37586.xml X0201 3 2004-02-27 0 0000356830 GENOME THERAPEUTICS CORP GENE 0001283535 PATOU GARY 100 BEAVER STREET WALTHAM MA 02453 0 1 0 0 Chief Medical Officer Stock Options (right to buy) 1.18 2006-01-08 2011-01-08 Common Stock 169646 D Stock Options (right to buy) 1.18 2005-12-12 2011-12-12 Common Stock 42411 D Stock Options (right to buy) .07 2007-02-10 2013-02-10 Common Stock 928463 D A 5 year vesting period. 20% of the options will vest on the one year anniversary date of the grant . The remaining options will vest monthly over the remaining four years of the vesting period. A 4 year vesting period. 20% of the options will vest on the one year anniversary date of the grant . The remaining options will vest monthly over the remaining three years of the vesting period. A 4 year vesting period. 20% of the options will vest on the one year anniversary date of the grant . The remaining options will vest monthly over the remaining three years of the vesting period. /s/ Gary Patou 2004-03-26 -----END PRIVACY-ENHANCED MESSAGE-----